14:21 , Mar 22, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Cancer; renal cancer Cell culture and mouse studies suggest the NME2 inhibitor stauprimide could help treat MYC-driven cancer. Stauprimide is known to inhibit NME2-mediated MYC transcription in normal cells. In multiple MYC-driven human cancer cell...